Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
Sijin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenlin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(The University of Texas MD Anderson Cancer Center), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yannan Yang(Fudan University), Jie Wang(Chongqing University), Guochao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kailun Fei(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 25
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Participation and yield of a population-based colorectal cancer screening programme in China
|Gut|2018|409
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
|The Lancet. Gastroenterology & hepatology|2024|248